Resultados de la búsqueda
Search results for "silence therapeutics"
59 results found for "silence therapeutics"
- Are you feeling fatigued?
But you don't have to suffer in silence. But you don't have to suffer in silence.
- What we don’t see also matters: immunology and research in MPN
When the body’s balance changesIn many cases, these mechanisms work silently and effectively. Research plays a key role in advancing knowledge, identifying new therapeutic targets, and developing
- Recognizing Excellence: Highlights from the 3rd MPN Spring Symposium Awards Ceremony
Hugh Rienhoff * MPN Voice UK * Protagonist Therapeutics Let's honor and learn from the awardees: Prof Summary Transcription Protagonist TherapeuticsThe award ceremony recognizes Protagonist Therapeutic for its innovative work in developing a new therapeutic product.
- Videos from the Webinar with Dr. Serge Verstovsek on the Future of MPN Treatment
Verstovsek, world-leading MPN researcher The Global MPN Scientific Foundation, in collaboration with Kartos Therapeutics Content Guide* PART 1 – A New Era: Navtemadlin and the Therapeutic Approach * Want to watch Parts 2 and * Why this matters PART 1 – A New Era: Navtemadlin and the Therapeutic ApproachDr.
- FDA Approves MIMRYLO™ (rusfertide), a New Treatment for Adults with Polycythemia Vera
of erythrocytosis in adults with polycythemia vera (PV), marking an important new development in the therapeutic For many patients, this requires repeated therapeutic phlebotomies, sometimes in addition to treatments The study also showed: * A reduction in the number of therapeutic phlebotomies. * Improved maintenance A different therapeutic approachMIMRYLO is administered as a once-weekly subcutaneous injection and works
- Virtual Meeting: Regain your strength - 30th January
this session, we will focus on the first stage post-diagnosis and engage in automatic writing as a therapeutic Register now and don’t miss out on this unique opportunity to explore the therapeutic benefits of writing
- Protagonist Announces Positive Results from REVIVE for PV
Protagonist Therapeutics, Inc. announces positive topline results from the blinded, placebo-controlled
- Summary of ASH 2024: Key Insights and Highlights
the Global MPN Scientific Foundation, attended this important event, where discussions focused on new therapeutic
- Virtual Meeting: Regain your strength - 13th March - Sesion 4
📢 Register now and don’t miss this unique opportunity to explore the therapeutic power of writing, connect
- Rusfertide's REVIVE Study Highlights 2-Year Efficacy in Polycythemia Vera (PV)
Protagonist Therapeutics, Inc. has unveiled compelling data from its Rusfertide REVIVE study during the
- Webinar | Introduction to Geron
patients, caregivers, and healthcare professionals to gain insight into the latest research and innovative therapeutic
- Virtual Meeting: Regain your strength - 27th February - Sesion 3
Register now and don’t miss out on this unique opportunity to explore the therapeutic benefits of writing










